Business
Easton Pharmaceuticals Announces That Easton and Its JV Partner, Alliance Group, Have Generated $40,000 in Revenues in the First Week of Operations
Easton Pharmaceuticals Announces That Easton and Its JV Partner, Alliance Group, Have Generated $40,000 in Revenues in the First Week of Operations.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\n\n Operations are Anticipated to Continually Increase, Which Includes Volume and Pricing, While it Prepares to Launch Its More Profitable Aggregate Operations  TORONTO, ON, June 11, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH) Announces that Easton and its JV partner 1124123 Ontario Limited (O/A - Alliance Group) generated $40,000 in in revenues in the first week of operations on its Georgina property. After the delivery of heavy machinery to the Georgina property, the company can disclose that operations have generated over $40,000 CDN in revenues in its first week of operations. The revenues received in its first week were from limited operations. Volume and pricing will both begin to increase in the coming weeks which will increase its healthy profit margins. New contracts with new customers who are classified as some of the biggest operators in Southern Ontario are being negotiated and are anticipated to soon close. Concurrent with these operations, Easton and Alliance are preparing to soon start operations on its much more lucrative and profitable aggregate business on its Georgina property as well as its medical marijuana operations which Alliance is working towards commencing. Additional updates will be disclosed as they progress including other segments of its business such as its recently executed agreement with BAYER and other initiatives.       In other news, Easton can disclose that it had high-level discussions last week with a Marijuana license holder from Jamaica, who is also a late stage LP applicant in Canada with regards to distribution and possible partnership. The companies will meet again in two weeks to further discuss their proposed partnership. About Easton Pharmaceuticals Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. The Company previously developed and owned an FDA-approved wound-healing medical drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton has partnered with BMV Medica S.A. and together own the exclusive distribution rights in Mexico and Latin America for two patented women's diagnostic products and ...